Get started
Pacific Biosciences of California, Inc.Pacific Biosciences of California, Inc.Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

PACB chart


Full chart

PACB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪282.53 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.2815 USD
Net income (FY)
‪−309.85 M‬ USD
Revenue (FY)
‪154.01 M‬ USD
Shares float
‪264.15 M‬
Beta (1Y)
0.22

Employees


Employees (FY)
575
Change (1Y)
−221 −27.76%
Revenue / Employee (1Y)
‪267.85 K‬ USD
Net income / Employee (1Y)
‪−538.87 K‬ USD

About Pacific Biosciences of California, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Christian O. Henry
Website
pacb.com
Headquarters
Menlo Park
Founded
2000
FIGI
BBG000QKXH20
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PACB news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

PACB highest yielding bonds


PACB5630687
Pacific Biosciences of California, Inc. 1.375% 15-DEC-2030
Yield to maturity
—
Maturity date
Dec 15, 2030
PACB5949325
Pacific Biosciences of California, Inc. 1.5% 15-AUG-2029
Yield to maturity
—
Maturity date
Aug 15, 2029

See all PACB bonds 


Check out other big names from the same industry as PACB.

Frequently Asked Questions


The current price of PACB is 0.9218 USD — it has decreased by −2.19% in the past 24 hours. Watch Pacific Biosciences of California, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Pacific Biosciences of California, Inc. stocks are traded under the ticker PACB.
PACB stock has fallen by −12.30% compared to the previous week, the month change is a −24.52% fall, over the last year Pacific Biosciences of California, Inc. has showed a −50.44% decrease.
We've gathered analysts' opinions on Pacific Biosciences of California, Inc. future price: according to them, PACB price has a max estimate of 3.00 USD and a min estimate of 1.00 USD. Watch PACB chart and read a more detailed Pacific Biosciences of California, Inc. stock forecast: see what analysts think of Pacific Biosciences of California, Inc. and suggest that you do with its stocks.
PACB reached its all-time high on Feb 11, 2021 with the price of 53.6900 USD, and its all-time low was 0.9501 USD and was reached on May 16, 2025. View more price dynamics on PACB chart.
See other stocks reaching their highest and lowest prices.
PACB stock is 4.96% volatile and has beta coefficient of 0.22. Track Pacific Biosciences of California, Inc. stock price on the chart and check out the list of the most volatile stocks — is Pacific Biosciences of California, Inc. there?
Today Pacific Biosciences of California, Inc. has the market capitalization of ‪276.62 M‬, it has increased by 1.78% over the last week.
Yes, you can track Pacific Biosciences of California, Inc. financials in yearly and quarterly reports right on TradingView.
Pacific Biosciences of California, Inc. is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
PACB earnings for the last quarter are −1.44 USD per share, whereas the estimation was −0.19 USD resulting in a −649.71% surprise. The estimated earnings for the next quarter are −0.18 USD per share. See more details about Pacific Biosciences of California, Inc. earnings.
Pacific Biosciences of California, Inc. revenue for the last quarter amounts to ‪37.15 M‬ USD, despite the estimated figure of ‪35.44 M‬ USD. In the next quarter, revenue is expected to reach ‪36.83 M‬ USD.
PACB net income for the last quarter is ‪−426.07 M‬ USD, while the quarter before that showed ‪3.57 M‬ USD of net income which accounts for ‪−12.03 K‬% change. Track more Pacific Biosciences of California, Inc. financial stats to get the full picture.
No, PACB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2025, the company has 575 employees. See our rating of the largest employees — is Pacific Biosciences of California, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pacific Biosciences of California, Inc. EBITDA is ‪−196.88 M‬ USD, and current EBITDA margin is −137.72%. See more stats in Pacific Biosciences of California, Inc. financial statements.
Like other stocks, PACB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pacific Biosciences of California, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pacific Biosciences of California, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pacific Biosciences of California, Inc. stock shows the strong sell signal. See more of Pacific Biosciences of California, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.